New Funding Opportunities Available Through the New Advanced Research Projects Agency for Health (ARPA-H) BAA
ARPA-H, or the Advanced Research Projects Agency for Health, is an agency within the National Institutes of Health (NIH) that aims to accelerate the development of breakthrough technologies and treatments for major diseases. ARPA-H has been likened to the Defense Advanced Research Projects Agency (DARPA), responsible for funding groundbreaking research in computer networking, GPS, and robotics.
The idea for ARPA-H was first proposed in 2020 by the Biden administration as part of its broader strategy to improve public health and pandemic preparedness. ARPA-H received $1.5 billion in funding in the most recent Omnibus and will be focused on funding high-risk, high-reward research projects that have the potential to transform the way we prevent and treat diseases.
As part of its efforts to establish ARPA-H, NIH issued a Broad Agency Announcement (BAA) on March 15th to solicit input from the scientific community on potential research areas and approaches.
The BAA outlines four initial funding areas of interest:
1. Health Science Futures
Development of innovative tools, technologies, and platforms to accelerate therapies that address rare diseases and conditions for which treatment options are limited.
2. Scalable Solutions
Development of innovative solutions that will improve access and affordability and address health ecosystem challenges that impede the effective and timely distribution of therapeutic interventions.
3. Proactive Health
Creation of new capabilities to identify and characterize disease risk, reduce comorbidities, and promote treatments and behaviors that reduce time spent in acute care and the likelihood of needing medical intervention.
4. Resilient Systems
Development of mechanisms and capabilities that will enhance the resiliency of systems in the face of crises such as pandemics, social disruption, climate change, molecular disturbances, and economic instability.
The BAA also emphasizes the importance of interdisciplinary collaboration and the need for innovative, high-risk, high-reward research that can transform biomedical research and improve human health.
The input gathered through the BAA process will inform the establishment of ARPA-H and the selection of research areas and projects that will be funded by the agency. The establishment of ARPA-H and the projects it funds have the potential to significantly accelerate progress in biomedical research and transform healthcare in the years to come.
Solicitation
The complete solicitation can be found at https://sam.gov/opp/73130e65035d427d825e647d95860251/view. Initial abstracts (3-page limit) are due by March 14, 2024.
If you are interested in exploring ARPA-H opportunities, EverGlade can help. EverGlade Consulting is a national consulting firm helping clients navigate the federal landscape. We work with technology-driven companies whose focus is to secure non-dilutive funding through the federal government. We offer services ranging from opportunity identification and proposal support through the implementation of systems to comply with federal regulations at agencies including BARDA, ARPA-H, ASPR, NIH, DTRA, JPEO, and DARPA.
For additional information about EverGlade’s recent success, visit:
EverGlade Consulting Helps Land up to $1 Billion in BARDA Funding for Biotechnology Company
EverGlade Consulting Assists United Safety Technology, Inc. in Securing $97 Million DOD Award
